Search results
Results from the WOW.Com Content Network
Eptifibatide is used to reduce the risk of acute cardiac ischemic events (death and/or myocardial infarction) in patients with unstable angina or non-ST-segment-elevation (e.g., non-Q-wave) myocardial infarction (i.e., non-ST-segment elevation acute coronary syndromes) both in patients who are to receive non surgery (conservative) medical treatment and those undergoing percutaneous coronary ...
Hydralazine is not used as a primary drug for treating hypertension because it elicits a reflex sympathetic stimulation of the heart (the baroreceptor reflex). [9] The sympathetic stimulation may increase heart rate and cardiac output, and in people with coronary artery disease may cause angina pectoris or myocardial infarction. [10]
The Acute Infarction Ramipril Efficacy (AIRE) trial [17] [25] showed a 27% reduction in mortality for patients receiving ramipril for chronic heart failure following a myocardial infarction. Ramipril was found to have similar results as telmisartan , an angiotensin II receptor blocker .
CK-MB starts to rise 2-4 hours after infarction, peaks around 24 hours, and returns to normal after 48 hours. Since CK-MB returns to normal more quickly, it can be useful to diagnose reinfarction, a second infarction that happens after 48 hours but before troponin levels go back to normal. A second heart attack happens following 10% of MIs.
An 80 mg capsule of extended-release propranolol A mixture of 20 mg and 10 mg propranolol tablets ... Myocardial infarction; ... are between 10 and 100 mg/L. ...
Antiplatelet drugs are widely used in primary and secondary prevention of thrombotic disease, especially myocardial infarction and ischemic stroke. [1] Antiplatelet therapy with one or more of these drugs decreases the ability of blood clots to form by interfering with the platelet activation process in primary hemostasis. Antiplatelet drugs ...
[25] [18] [26] [27] The economic efficiency of using lysine acetylsalicylate in the secondary prevention of ischemic stroke and myocardial infarction has also been demonstrated in one pharmacoeconomic study. [28] Lysine acetylsalicylate is generally reserved for patients with urgent need of antiplatelet therapy with no oral or nasogastric ...
May increase myocardial ischemia. Blood pressure, pulse, and ECG should be constantly monitored. Amrinone should only be diluted with normal saline or 1/2 normal saline; no dextrose solutions should be used. Furosemide, a loop diuretic, should not be administered into an IV line delivering amrinone.